Patent · US Expired

Melanocortin 1 receptor selective compounds

US7662782B2 · kind B2 · utility

5Cited by

2References

39Claims

0Family size

Assignee

Action Pharma A/S · DK

Inventors

Michael Szardenings · Leipzig, DE
Ruta Muceniece · Uppsala, SE
Ilze Mutule · Uppsala, SE
Felikss Mutulis · Uppsala, SE
Jarl Wikberg · Åkersberga, SE

Key dates

Filing date	Dec 29, 2005
Grant date	Feb 16, 2010
Priority date	—
Expiry date	Jan 5, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to methods of treatment comprising administering a compound of the general formula (1):to a patient or a healthy individual.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.